4584 — Kidswell Bio Income Statement
0.000.00%
Last trade - 00:00
- ¥5bn
- ¥5bn
- ¥3bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,022 | 1,078 | 997 | 1,569 | 2,776 |
Cost of Revenue | |||||
Gross Profit | 609 | 425 | 877 | 1,019 | 1,526 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,865 | 8,371 | 1,968 | 2,487 | 3,359 |
Operating Profit | -844 | -7,293 | -971 | -918 | -582 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -854 | -7,314 | -1,000 | -534 | -656 |
Provision for Income Taxes | |||||
Net Income After Taxes | -856 | -7,316 | -1,001 | -535 | -657 |
Net Income Before Extraordinary Items | |||||
Net Income | -856 | -7,316 | -1,001 | -535 | -657 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -856 | -7,316 | -1,001 | -535 | -657 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -42.6 | -120 | -34.6 | -17.4 | -20.1 |
Dividends per Share |